Kathy Kang is an investment associate of Co-win Ventures. Kathy Kang joined Co-win Ventures in 2020. She started biotech investment career as analyst in Fosun in 2018, promoted as associate in 2019, she was one of the key builders of Fosun Health Fund. She has participated in deals of Cambridge Innovation Capital (CIC), Biomissile (M&A), Aucta Pharma, ZWI Therapeutics, Bioelectronica.
Kathy Kang holds an Ph.D. from Fudan University in pharmaceutical and B.S from Shandong University, she was the outstanding winner of “Academic Star” in Fudan in 2017.